Literature DB >> 14557142

Relationship between antidepressant medication treatment and suicide in adolescents.

Mark Olfson1, David Shaffer, Steven C Marcus, Ted Greenberg.   

Abstract

CONTEXT: A decade of increasing antidepressant medication treatment for adolescents and corresponding declines in suicide rates raise the possibility that antidepressants have helped prevent youth suicide.
OBJECTIVE: To evaluate the relationship between regional changes in antidepressant medication treatment and suicide in adolescents from 1990 to 2000.
DESIGN: Analysis of prescription data from the nation's largest pharmacy benefit management organization, national suicide mortality files, regional sociodemographic data from the 1990 and 2000 US Census, and regional data on physicians per capita. PARTICIPANTS: Youth aged 10 to 19 years who filled a prescription for antidepressant medication and same-aged completed suicides from 588 three-digit ZIP code regions in the United States. MAIN OUTCOME MEASURES: The relationship between regional change in antidepressant medication treatment and suicide rate stratified by sex, age group, regional median income, and regional racial composition.
RESULTS: There was a significant adjusted negative relationship between regional change in antidepressant medication treatment and suicide during the study period. A 1% increase in adolescent use of antidepressants was associated with a decrease of 0.23 suicide per 100 000 adolescents per year (beta = -.023, t = -5.14, P<.001). In stratified adjusted analyses, significant inverse relationships were present among males (beta = -.032, t = -3.81, P<.001), youth aged 15 to 19 years (beta = -.029, t = -3.43, P<.001), and regions with lower family median incomes (beta = -.023, t = -3.73, P<.001).
CONCLUSIONS: An inverse relationship between regional change in use of antidepressants and suicide raises the possibility of a role for using antidepressant treatment in youth suicide prevention efforts, especially for males, older adolescents, and adolescents who reside in lower-income regions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557142     DOI: 10.1001/archpsyc.60.9.978

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  74 in total

Review 1.  Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?

Authors:  Robert D Gibbons; J John Mann
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

Review 2.  Antidepressants and suicide: what is the balance of benefit and harm.

Authors:  David Gunnell; Deborah Ashby
Journal:  BMJ       Date:  2004-07-03

Review 3.  Approach to adolescent suicide prevention.

Authors:  Marcia Kostenuik; Mohana Ratnapalan
Journal:  Can Fam Physician       Date:  2010-08       Impact factor: 3.275

Review 4.  Pharmacogenomics of suicidal events.

Authors:  David Brent; Nadine Melhem; Gustavo Turecki
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

Review 5.  Continuation and maintenance therapy of early-onset major depressive disorder.

Authors:  Graham J Emslie; Taryn L Mayes; Maryse Ruberu
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 6.  Treating depression in children and adolescents: what options now?

Authors:  Christopher K Varley
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 7.  Risk of adverse behavioral effects with pediatric use of antidepressants.

Authors:  Wayne K Goodman; Tanya K Murphy; Eric A Storch
Journal:  Psychopharmacology (Berl)       Date:  2006-12-19       Impact factor: 4.530

8.  US suicide rates by age group, 1970-2002: an examination of recent trends.

Authors:  Robert E McKeown; Steven P Cuffe; Richard M Schulz
Journal:  Am J Public Health       Date:  2006-10       Impact factor: 9.308

9.  Antidepressants and youth: healing or harmful?

Authors:  Sara Markowitz; Alison Cuellar
Journal:  Soc Sci Med       Date:  2007-03-19       Impact factor: 4.634

10.  Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning.

Authors:  Tanvir Singh; Ashwin Prakash; Theodore Rais; Neeta Kumari
Journal:  Psychiatry (Edgmont)       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.